(Q35057869)

English

High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial

scientific article

Statements

High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial (English)
0 references
0 references
0 references
0 references
0 references
0 references
Silvia M Trisolini

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit